Protein-free calf blood extract - Lee's Pharmaceutical

Drug Profile

Protein-free calf blood extract - Lee's Pharmaceutical

Alternative Names: Eyprotor

Latest Information Update: 30 May 2012

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Lees Pharmaceutical Holdings
  • Class Anti-inflammatories; Cicatrizants; Eye disorder therapies
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Marketed Corneal injuries

Most Recent Events

  • 30 May 2012 Launched for Corneal injuries in China (Topical)
  • 13 May 2008 Registered for Corneal injuries in China (Topical)
  • 31 Jan 2005 Clinical trials in Corneal injuries in China (Topical)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top